secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001601485-25-000046
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics reports year-end 2024 results; press release text unreadable
--------------------------------------------------------------------------------

- Filing announces financial results for year ended Dec 31, 2024 and corporate updates.
- Attached press release (Exhibit 99.1) contains extensive encoding corruption; specific figures not extractable.
- No legible quantitative guidance or material non-financial updates identified in the exhibit.
- Management change or other items not mentioned; only operational update alluded to.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000046/0001601485-25-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000046/angn-20250331.htm
  HTML page:      https://secwatch.observer/filing/0001601485-25-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer